primary hdf Search Results


primary dermal fibroblast; normal, human, adult  (ATCC)
99
ATCC primary dermal fibroblast; normal, human, adult
Primary Dermal Fibroblast; Normal, Human, Adult, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary dermal fibroblast; normal, human, adult/product/ATCC
Average 99 stars, based on 1 article reviews
primary dermal fibroblast; normal, human, adult - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
hdf human primary cells  (ScienCell)
90
ScienCell hdf human primary cells
Hdf Human Primary Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hdf human primary cells/product/ScienCell
Average 90 stars, based on 1 article reviews
hdf human primary cells - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human dermal fibroblasts (hdfs)  (Tissue Solutions)
90
Tissue Solutions human dermal fibroblasts (hdfs)
Antioxidative and anti‐inflammatory capacity of bakuchiol and retinol. (a) Antioxidative efficacy of bakuchiol (100 μM) or retinol (100 μM) compared to the high standard trolox (25 μM) and the solvent control determined by a DPPH antioxidant assay through absorbance measurement at 524 nm after 10, 30 and 60 min. N = 12. (b) Antioxidative power expressed in antioxidative units of bakuchiol, retinol or the high standard vitamin C (vit. C) determined using electron spin resonance spectroscopy. (c) ELISA‐based measurement of prostaglandin E2 (PGE2) levels in unstressed human dermal <t>fibroblasts</t> <t>(HDFs),</t> LPS‐stressed control HDFs, and in LPS‐stressed HDFs treated with the high standard diclofenac (25 ng/mL), bakuchiol or retinol (both applied at 1.25, 2.5, 5, 10 μM) for 24 h. N = 12. (d) Macrophage migration inhibitory factor (MIF) protein levels in unstressed HDFs, in HDFs stressed by a DPBS incubation and in stressed HDFs treated with bakuchiol or retinol (both applied at 1 and 10 μM) for 48 h determined by ELISA. N = 10. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison based on Blom‐transformed ranks for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]
Human Dermal Fibroblasts (Hdfs), supplied by Tissue Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human dermal fibroblasts (hdfs)/product/Tissue Solutions
Average 90 stars, based on 1 article reviews
human dermal fibroblasts (hdfs) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human dermal fibroblast (hdf) primary cells cck027  (HiMedia Laboratories)
90
HiMedia Laboratories human dermal fibroblast (hdf) primary cells cck027
Antioxidative and anti‐inflammatory capacity of bakuchiol and retinol. (a) Antioxidative efficacy of bakuchiol (100 μM) or retinol (100 μM) compared to the high standard trolox (25 μM) and the solvent control determined by a DPPH antioxidant assay through absorbance measurement at 524 nm after 10, 30 and 60 min. N = 12. (b) Antioxidative power expressed in antioxidative units of bakuchiol, retinol or the high standard vitamin C (vit. C) determined using electron spin resonance spectroscopy. (c) ELISA‐based measurement of prostaglandin E2 (PGE2) levels in unstressed human dermal <t>fibroblasts</t> <t>(HDFs),</t> LPS‐stressed control HDFs, and in LPS‐stressed HDFs treated with the high standard diclofenac (25 ng/mL), bakuchiol or retinol (both applied at 1.25, 2.5, 5, 10 μM) for 24 h. N = 12. (d) Macrophage migration inhibitory factor (MIF) protein levels in unstressed HDFs, in HDFs stressed by a DPBS incubation and in stressed HDFs treated with bakuchiol or retinol (both applied at 1 and 10 μM) for 48 h determined by ELISA. N = 10. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison based on Blom‐transformed ranks for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]
Human Dermal Fibroblast (Hdf) Primary Cells Cck027, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human dermal fibroblast (hdf) primary cells cck027/product/HiMedia Laboratories
Average 90 stars, based on 1 article reviews
human dermal fibroblast (hdf) primary cells cck027 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
primary human dermal fibroblasts (hdf) cells  (Biochrom)
90
Biochrom primary human dermal fibroblasts (hdf) cells
Antioxidative and anti‐inflammatory capacity of bakuchiol and retinol. (a) Antioxidative efficacy of bakuchiol (100 μM) or retinol (100 μM) compared to the high standard trolox (25 μM) and the solvent control determined by a DPPH antioxidant assay through absorbance measurement at 524 nm after 10, 30 and 60 min. N = 12. (b) Antioxidative power expressed in antioxidative units of bakuchiol, retinol or the high standard vitamin C (vit. C) determined using electron spin resonance spectroscopy. (c) ELISA‐based measurement of prostaglandin E2 (PGE2) levels in unstressed human dermal <t>fibroblasts</t> <t>(HDFs),</t> LPS‐stressed control HDFs, and in LPS‐stressed HDFs treated with the high standard diclofenac (25 ng/mL), bakuchiol or retinol (both applied at 1.25, 2.5, 5, 10 μM) for 24 h. N = 12. (d) Macrophage migration inhibitory factor (MIF) protein levels in unstressed HDFs, in HDFs stressed by a DPBS incubation and in stressed HDFs treated with bakuchiol or retinol (both applied at 1 and 10 μM) for 48 h determined by ELISA. N = 10. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison based on Blom‐transformed ranks for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]
Primary Human Dermal Fibroblasts (Hdf) Cells, supplied by Biochrom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human dermal fibroblasts (hdf) cells/product/Biochrom
Average 90 stars, based on 1 article reviews
primary human dermal fibroblasts (hdf) cells - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Antioxidative and anti‐inflammatory capacity of bakuchiol and retinol. (a) Antioxidative efficacy of bakuchiol (100 μM) or retinol (100 μM) compared to the high standard trolox (25 μM) and the solvent control determined by a DPPH antioxidant assay through absorbance measurement at 524 nm after 10, 30 and 60 min. N = 12. (b) Antioxidative power expressed in antioxidative units of bakuchiol, retinol or the high standard vitamin C (vit. C) determined using electron spin resonance spectroscopy. (c) ELISA‐based measurement of prostaglandin E2 (PGE2) levels in unstressed human dermal fibroblasts (HDFs), LPS‐stressed control HDFs, and in LPS‐stressed HDFs treated with the high standard diclofenac (25 ng/mL), bakuchiol or retinol (both applied at 1.25, 2.5, 5, 10 μM) for 24 h. N = 12. (d) Macrophage migration inhibitory factor (MIF) protein levels in unstressed HDFs, in HDFs stressed by a DPBS incubation and in stressed HDFs treated with bakuchiol or retinol (both applied at 1 and 10 μM) for 48 h determined by ELISA. N = 10. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison based on Blom‐transformed ranks for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]

Journal: International Journal of Cosmetic Science

Article Title: Multidirectional activity of bakuchiol against cellular mechanisms of facial ageing ‐ Experimental evidence for a holistic treatment approach

doi: 10.1111/ics.12784

Figure Lengend Snippet: Antioxidative and anti‐inflammatory capacity of bakuchiol and retinol. (a) Antioxidative efficacy of bakuchiol (100 μM) or retinol (100 μM) compared to the high standard trolox (25 μM) and the solvent control determined by a DPPH antioxidant assay through absorbance measurement at 524 nm after 10, 30 and 60 min. N = 12. (b) Antioxidative power expressed in antioxidative units of bakuchiol, retinol or the high standard vitamin C (vit. C) determined using electron spin resonance spectroscopy. (c) ELISA‐based measurement of prostaglandin E2 (PGE2) levels in unstressed human dermal fibroblasts (HDFs), LPS‐stressed control HDFs, and in LPS‐stressed HDFs treated with the high standard diclofenac (25 ng/mL), bakuchiol or retinol (both applied at 1.25, 2.5, 5, 10 μM) for 24 h. N = 12. (d) Macrophage migration inhibitory factor (MIF) protein levels in unstressed HDFs, in HDFs stressed by a DPBS incubation and in stressed HDFs treated with bakuchiol or retinol (both applied at 1 and 10 μM) for 48 h determined by ELISA. N = 10. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison based on Blom‐transformed ranks for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]

Article Snippet: Human dermal fibroblasts (HDFs) from multiple donors were obtained from Tissue Solutions Ltd (Glasgow, UK), Lonza (Basel, Switzerland), tebu‐bio (Heerhugowaard, Netherlands) or isolated from full‐thickness skin explants purchased from Alphenyx (Marseille, France) as described before [ ].

Techniques: Solvent, Control, Antioxidant Assay, Electron Paramagnetic Resonance, Spectroscopy, Enzyme-linked Immunosorbent Assay, Migration, Incubation, Comparison, Transformation Assay

Effects of bakuchiol and retinol on cell activity and major ECM components. (a) Fibroblast growth factor 7 (FGF7) protein levels in control HDFs and in HDFs treated with 10 μM bakuchiol or retinol for 24 h. N = 13. (b) Quantification of WST‐1 metabolization in control HDFs and in HDFs treated with 10% triton‐X, bakuchiol or retinol (both applied at 1 and 10 μM) for 72 h. Difference in absorbance at 620 and 450 nm is depicted. N = 12. (c) Collagen, type VII, alpha 1 (COL7A1) protein levels in control HDFs and in HDFs treated with the high standard TGF‐β (10 ng/mL) and sodium ascorbate (SA; 11 μg/mL), as well as with bakuchiol or retinol (4 h: 1 and 10 μM, extended incubation: 10 μM for both test substances) for 4 h or for an extended incubation time (72 h or 96 h depending on cell confluence). N = 10 for 4 h, n = 11 for extended incubation. (d) Collagen, type I, alpha 1 (COL1A1) protein levels in control HDFs and in HDFs treated with the high standard TGF‐β and SA as aforementioned, bakuchiol or retinol (both applied at 1 and 10 μM) for 4 h. N = 11. (e) Fibronectin (FN) protein levels in control HDFs and in HDFs treated with 10 μM bakuchiol or retinol for 24 h. N = 11. All protein levels were determined by ELISA. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]

Journal: International Journal of Cosmetic Science

Article Title: Multidirectional activity of bakuchiol against cellular mechanisms of facial ageing ‐ Experimental evidence for a holistic treatment approach

doi: 10.1111/ics.12784

Figure Lengend Snippet: Effects of bakuchiol and retinol on cell activity and major ECM components. (a) Fibroblast growth factor 7 (FGF7) protein levels in control HDFs and in HDFs treated with 10 μM bakuchiol or retinol for 24 h. N = 13. (b) Quantification of WST‐1 metabolization in control HDFs and in HDFs treated with 10% triton‐X, bakuchiol or retinol (both applied at 1 and 10 μM) for 72 h. Difference in absorbance at 620 and 450 nm is depicted. N = 12. (c) Collagen, type VII, alpha 1 (COL7A1) protein levels in control HDFs and in HDFs treated with the high standard TGF‐β (10 ng/mL) and sodium ascorbate (SA; 11 μg/mL), as well as with bakuchiol or retinol (4 h: 1 and 10 μM, extended incubation: 10 μM for both test substances) for 4 h or for an extended incubation time (72 h or 96 h depending on cell confluence). N = 10 for 4 h, n = 11 for extended incubation. (d) Collagen, type I, alpha 1 (COL1A1) protein levels in control HDFs and in HDFs treated with the high standard TGF‐β and SA as aforementioned, bakuchiol or retinol (both applied at 1 and 10 μM) for 4 h. N = 11. (e) Fibronectin (FN) protein levels in control HDFs and in HDFs treated with 10 μM bakuchiol or retinol for 24 h. N = 11. All protein levels were determined by ELISA. Results are depicted as mean ± SD. Statistics were performed by RM‐ANOVA with post‐hoc pairwise comparison for Figure or by a pairwise Wilcoxon signed rank test for Figure . Significant differences are marked with an asterisk (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com ]

Article Snippet: Human dermal fibroblasts (HDFs) from multiple donors were obtained from Tissue Solutions Ltd (Glasgow, UK), Lonza (Basel, Switzerland), tebu‐bio (Heerhugowaard, Netherlands) or isolated from full‐thickness skin explants purchased from Alphenyx (Marseille, France) as described before [ ].

Techniques: Activity Assay, Control, Incubation, Enzyme-linked Immunosorbent Assay, Comparison